Clinical Trial Update: Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

View source ↗

Summary

A terminated clinical trial explored prognostic biomarkers for progression of invasive squamous cell carcinoma, with emphasis on squamous cell carcinoma of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: Mayo Clinic | Conditions: Carcinoma, Squamous Cell, Carcinoma, Squamous | Status: TERMINATED